プライマリ・ショーグレン症候群とICA69の欠乏症
Shawn Winer1, Igor Astsaturov, Roy Cheung
1Hospital for Sick Children, Research Institute, ON, Toronto, Canada.
Lancet (London, England)
|October 18, 2002
まとめ
ICA69は,ショーグレン症候群の重要な自己抗原として特定され,疾患の進行を促しています. ICA69を標的とした免疫療法は,この自己免疫疾患の治療において,後期段階でも有望であることが示されています.
科学分野:
- 免疫学 免疫学とは
- 自己免疫とは,自己免疫である.
- エンドクリノロジー エンドクリノロジー
背景:
- ショーグレン症候群は,唾液腺と涙腺に影響を与える一般的な自己免疫疾患です.
- ショーグレン症候群の正確な原因と病原性は,未だに十分に理解されていない.
- ICA69は,様々な腺に存在する自己抗原であり,自己免疫反応に関与している.
研究 の 目的:
- シェーグレン症候群の自己免疫性の発達におけるICA69の役割を調査する.
- 診断マーカーおよび治療標的としてのICA69の可能性を評価する.
主な方法:
- Sjögrens症候群をモデル化するためにICA69欠乏のNOD先天性マウスを生成しました.
- プライマリ・シューグレン症候群と全身性白血球性狼の患者におけるICA69の自己免疫を分析した.
- NODマウスにおけるICA69を標的としたプロトタイプペプチドワクチンの有効性を評価した.
主要な成果:
- ICA69欠乏症は,涙腺疾患と縮小唾液腺疾患からNODマウスを保護しました.
- ICA69に特異的なT細胞の蓄積は,NODマウスの唾液排水リンパ節に観察されました.
- ICA69に対するオートレアクティビティは,原発性シェーグレン症候群の患者では一般的であったが,対照群やSLE患者ではそうではなかった.
- ICA69を標的とした治療ペプチドワクチン接種は,NODマウスにおける既定のSjögren症候群を減少させた.
結論:
- ICA69は,シェーグレン症候群の進行に寄与する新しい自己抗原であり,診断マーカーとして機能する可能性があります.
- ICA69を標的とした免疫療法は,Sjögren症候群の治療の可能性を示しており,関連する動物モデルでは,進行した疾患段階でも有効性を示しています.
関連する概念動画
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...